Health ❯Healthcare ❯Pharmaceuticals ❯Drug Regulation

FDA Actions

FDA Seizes Counterfeit Ozempic in U.S. Supply Chain

The FDA and Novo Nordisk are investigating the safety of fake Ozempic products following reports of adverse events.

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions